MARKET

CANF

CANF

Can-Fite BioPharma Ltd.
AMEX
3.250
-0.230
-6.61%
After Hours: 3.270 +0.02 +0.62% 17:59 07/08 EDT
OPEN
3.400
PREV CLOSE
3.480
HIGH
3.550
LOW
3.250
VOLUME
82.95K
TURNOVER
--
52 WEEK HIGH
21.00
52 WEEK LOW
2.560
MARKET CAP
6.96M
P/E (TTM)
-0.0018
1D
5D
1M
3M
1Y
5Y
1D
Can-Fite Completes Key Phase 3 Psoriasis Enrolment Milestone for Piclidenoson
TipRanks · 2d ago
Can-Fite BioPharma enrolls 247 patients in Piclidenoson trial
TipRanks · 2d ago
Can-Fite BioPharma Completes Enrolment Of First 247 Patients In Pivotal Phase 3 Study Evaluating Piclidenoson For Treatment Of Moderate-To-Severe Plaque Psoriasis
Benzinga · 2d ago
CAN-FITE ACHIEVES KEY PIVOTAL PHASE 3 PSORIASIS MILESTONE WITH COMPLETION OF PATIENT ENROLMENT FOR THE INTERIM ANALYSIS: DATA EXPECTED Q4 2026/Q1 2027
Reuters · 2d ago
Weekly Report: what happened at CANF last week (0629-0703)?
Weekly Report · 2d ago
11 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 6d ago
Can-Fite Biopharma Price Target Raised to $8.00/Share From $5.00 by HC Wainwright & Co.
Dow Jones · 6d ago
HC Wainwright & Co. Reiterates Buy on Can Fite Biopharma, Raises Price Target to $8
Benzinga · 6d ago
More
About CANF
Can Fite Biopharma Ltd is an Israel-based clinical-stage biopharmaceutical company engaged in developing orally bioavailable small molecule therapeutic products for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. The Company co-develop formulations of cannabis components for the treatment of cancer, inflammatory, autoimmune, and metabolic diseases. Its technology utilizes the Gi protein associated A3AR as a therapeutic target. A3AR is expressed in inflammatory and cancer cells, and not significantly expressed in normal cells, suggesting that the receptor could be a target for pharmacological intervention.

Webull offers Can Fite Biopharma Ltd stock information, including AMEX: CANF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CANF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CANF stock methods without spending real money on the virtual paper trading platform.